“CXR is the 1st line exam for multiple indications, however, CXR reading is particularly difficult. AI has the ability to detect subtle findings that require urgent management or that can highly impact patient prognosis, including signs of cancer, increasing the performance of radiologists.”
ChestView
ChestView AI enhances the detection of urgent findings like pneumothorax, pleural effusion, and consolidation, as well as early cancer indicators such as nodules, and mediastinal mass. Co-developed with AP-HP and grounded on a robust database partly cross-referenced with CT-scan, it is now widely used in private and public facilities worldwide.
CE
ChestView in action
-
Indication
49 years old male, history of high grade osteosarcoma, amputation of the tibia in 2010.
Results
ChestView detects a right paravertebral mass corresponding to a recurrence of the osteosarcoma, confirmed by CT and biopsy.
-
Indication
66 y.o. Male, active smoker (30 pack/year) with a chronic cough and altered general condition (weight loss, asthenia).
Results
ChestView detects a nodule in the apex of the right upper lobe, confirmed by CT.
Better patient care
Enhance the quality of care by minimizing overlooked anomalies; our study has shown a notable increase in sensitivity for all abnormalities.
Improving workflow
Over 70% of Chest X-rays are labeled as normal. ChestView accelerates prioritization with a unique design that merges vital findings and high sensitivity, assisting in patient triage.
Empowering readers
Reading Chest X-rays is challenging for all readers. ChestView aids by cutting down reading time and aims to serve as a copilot, bolstering their decision-making process.
